Onderneming Shin Nippon Biomedical Laboratories, Ltd. OTC Markets
Aandelen
SBLOF
JP3379950003
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,97 USD | -.--% | -.--% | -.--% |
Vakgebied
Aantal werknemers: 1 341
Verkoop per activiteit
JPY in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Contract Research Organization
97,0
%
| 23 924 | 95,4 % | 25 661 | 97,0 % | +7,26% |
Medipolis
1,8
%
| 601 | 2,4 % | 478 | 1,8 % | -20,52% |
Others
1,1
%
| 549 | 2,2 % | 300 | 1,1 % | -45,29% |
Translational Research
0,0
%
| 16 | 0,1 % | 12 | 0,0 % | -29,19% |
Verkoop per regio
JPY in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
67,3
%
| 18 515 | 73,8 % | 17 812 | 67,3 % | -3,80% |
United States
16,9
%
| 3 843 | 15,3 % | 4 482 | 16,9 % | +16,62% |
South Korea
14,2
%
| - | - | 3 763 | 14,2 % | - |
Other
1,5
%
| 2 733 | 10,9 % | 393 | 1,5 % | -85,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 01-09-81 |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 01-05-02 |
Terumasa Hirai
CMP | Compliance Officer | - | 01-04-84 |
Shunji Haruta
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-01 |
Ken Takanashi
COO | Chief Operating Officer | 60 | 01-12-02 |
Ichiro Nagata
BRD | Director/Board Member | 38 | 01-04-17 |
Kyomi Nagatoshi
IRC | Investor Relations Contact | - | 01-02-02 |
Hiroyuki Izumi
PRN | Corporate Officer/Principal | - | 01-04-92 |
Masakazu Suda
AUD | Comptroller/Controller/Auditor | 62 | 01-08-90 |
Toshihiko Makino
AUD | Comptroller/Controller/Auditor | - | 01-04-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 01-09-81 |
Ichiro Nagata
BRD | Director/Board Member | 38 | 01-04-17 |
Sales & Marketing | 64 | 01-11-02 | |
Corporate Officer/Principal | 56 | 01-06-99 | |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 01-05-02 |
Hideshi Tsusaki
PRN | Corporate Officer/Principal | 57 | 01-04-96 |
Director/Board Member | 66 | 01-06-15 | |
Director/Board Member | 68 | 01-06-15 | |
Tsuyoshi Hanada
BRD | Director/Board Member | - | 26-06-20 |
Keiko Toya
BRD | Director/Board Member | 60 | 01-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 41 632 400 | 19 291 331 ( 46,34 %) | 469 ( 0,001127 %) | 46,34 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
WAVE LIFE SCIENCES LTD. 53.83% | 2 100 000 | 53.83% | 12 978 000 $ |
TMS CO., LTD. 3.56% | 1 433 320 | 3.56% | 1 915 417 $ |
400 | 0.00% | 3 457 $ |
Bedrijfsgegevens
Shin Nippon Biomedical Laboratories, Ltd.
St. Luke's Tower, 28/F 8-1 Akashi-cho
104-0044, Tokyo
+81 9 9294 3389
http://www.snbl.co.jpSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,59% | 45,51 mld. | |
-9,89% | 38,52 mld. | |
+38,08% | 38,13 mld. | |
+27,12% | 30,74 mld. | |
-8,64% | 26,03 mld. | |
+11,81% | 25,92 mld. | |
+45,08% | 14,13 mld. | |
+32,85% | 12,73 mld. | |
-7,19% | 11,29 mld. |
- Beurs
- Aandelen
- Koers 2395
- Koers SBLOF
- Onderneming Shin Nippon Biomedical Laboratories, Ltd.